Literature DB >> 27541985

Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats.

Maria Xilouri1, Oeystein Roed Brekk1,2, Alexia Polissidis1, Margarita Chrysanthou-Piterou3, Ismini Kloukina4,5, Leonidas Stefanis1,6.   

Abstract

Chaperone-mediated autophagy (CMA) involves the selective lysosomal degradation of cytosolic proteins such as SNCA (synuclein α), a protein strongly implicated in Parkinson disease (PD) pathogenesis. However, the physiological role of CMA and the consequences of CMA failure in the living brain remain elusive. Here we show that CMA inhibition in the adult rat substantia nigra via adeno-associated virus-mediated delivery of short hairpin RNAs targeting the LAMP2A receptor, involved in CMA's rate limiting step, was accompanied by intracellular accumulation of SNCA-positive puncta, which were also positive for UBIQUITIN, and in accumulation of autophagic vacuoles within LAMP2A-deficient nigral neurons. Strikingly, LAMP2A downregulation resulted in progressive loss of nigral dopaminergic neurons, severe reduction in striatal dopamine levels/terminals, increased astro- and microgliosis and relevant motor deficits. Thus, this study highlights for the first time the importance of the CMA pathway in the dopaminergic system and suggests that CMA impairment may underlie PD pathogenesis.

Entities:  

Keywords:  LAMP2A; Parkinson disease; chaperone-mediated autophagy; lysosomes; synuclein α

Mesh:

Substances:

Year:  2016        PMID: 27541985      PMCID: PMC5103347          DOI: 10.1080/15548627.2016.1214777

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  41 in total

Review 1.  Behavioral tests for preclinical intervention assessment.

Authors:  Timothy Schallert
Journal:  NeuroRx       Date:  2006-10

2.  Age-related decline in chaperone-mediated autophagy.

Authors:  A M Cuervo; J F Dice
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

3.  Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease.

Authors:  Karen E Murphy; Amanda M Gysbers; Sarah K Abbott; Adena S Spiro; Akiko Furuta; Antony Cooper; Brett Garner; Tomohiro Kabuta; Glenda M Halliday
Journal:  Mov Disord       Date:  2015-01-16       Impact factor: 10.338

Review 4.  Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies.

Authors:  Kostas Vekrellis; Leonidas Stefanis
Journal:  Expert Opin Ther Targets       Date:  2012-04       Impact factor: 6.902

5.  Consequences of the selective blockage of chaperone-mediated autophagy.

Authors:  Ashish C Massey; Susmita Kaushik; Guy Sovak; Roberta Kiffin; Ana Maria Cuervo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

Review 6.  The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Authors:  Hilal A Lashuel; Cassia R Overk; Abid Oueslati; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2013-01       Impact factor: 34.870

7.  LAMP2A as a therapeutic target in Parkinson disease.

Authors:  Maria Xilouri; Oeystein Roed Brekk; Deniz Kirik; Leonidas Stefanis
Journal:  Autophagy       Date:  2013-10-08       Impact factor: 16.016

8.  Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.

Authors:  John E Duda; Benoit I Giasson; Meghann E Mabon; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2002-08       Impact factor: 10.422

9.  A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals.

Authors:  Jonathan Moss; J Paul Bolam
Journal:  J Neurosci       Date:  2008-10-29       Impact factor: 6.167

10.  Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.

Authors:  Maria Xilouri; Tereza Vogiatzi; Kostas Vekrellis; David Park; Leonidas Stefanis
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

View more
  41 in total

Review 1.  The coming of age of chaperone-mediated autophagy.

Authors:  Susmita Kaushik; Ana Maria Cuervo
Journal:  Nat Rev Mol Cell Biol       Date:  2018-06       Impact factor: 94.444

Review 2.  Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles.

Authors:  Lorenzo Galluzzi; José Manuel Bravo-San Pedro; Beth Levine; Douglas R Green; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2017-05-19       Impact factor: 84.694

3.  Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microglia.

Authors:  Maria Karamita; Christopher Barnum; Wiebke Möbius; Malú G Tansey; David E Szymkowski; Hans Lassmann; Lesley Probert
Journal:  JCI Insight       Date:  2017-04-20

Review 4.  The unlikely partnership between LRRK2 and α-synuclein in Parkinson's disease.

Authors:  Noémie Cresto; Camille Gardier; Francesco Gubinelli; Marie-Claude Gaillard; Géraldine Liot; Andrew B West; Emmanuel Brouillet
Journal:  Eur J Neurosci       Date:  2018-10-24       Impact factor: 3.386

Review 5.  Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration.

Authors:  Wesley Peng; Georgia Minakaki; Maria Nguyen; Dimitri Krainc
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

6.  Lycium barbarum Polysaccharide Promotes Nigrostriatal Dopamine Function by Modulating PTEN/AKT/mTOR Pathway in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Murine Model of Parkinson's Disease.

Authors:  Xiaohong Wang; Lei Pang; Yanqing Zhang; Jiang Xu; Dongyi Ding; Tianli Yang; Qian Zhao; Fan Wu; Fei Li; Haiwei Meng; Duonan Yu
Journal:  Neurochem Res       Date:  2018-03-28       Impact factor: 3.996

7.  Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease.

Authors:  Brian Spencer; Ivy Trinh; Edward Rockenstein; Michael Mante; Jazmin Florio; Anthony Adame; Omar M A El-Agnaf; Changyoun Kim; Eliezer Masliah; Robert A Rissman
Journal:  Neurobiol Dis       Date:  2019-03-05       Impact factor: 5.996

Review 8.  Dysfunction of chaperone-mediated autophagy in human diseases.

Authors:  Zhaozhong Liao; Bin Wang; Wenjing Liu; Qian Xu; Lin Hou; Jinlian Song; Qingming Guo; Ning Li
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

Review 9.  Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases.

Authors:  Nard Kubben; Tom Misteli
Journal:  Nat Rev Mol Cell Biol       Date:  2017-08-09       Impact factor: 94.444

Review 10.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.